AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress.

Oxford open immunology Pub Date : 2025-05-12 eCollection Date: 2025-01-01 DOI:10.1093/oxfimm/iqaf004
Gabriel Kalweit, Evelyn Ullrich, Joschka Boedecker, Roland Mertelsmann, Maria Kalweit
{"title":"AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress.","authors":"Gabriel Kalweit, Evelyn Ullrich, Joschka Boedecker, Roland Mertelsmann, Maria Kalweit","doi":"10.1093/oxfimm/iqaf004","DOIUrl":null,"url":null,"abstract":"<p><p>The molecular complexity of cancer presents significant challenges to traditional therapeutic approaches, necessitating the development of innovative treatment strategies capable of addressing the disease's dynamic nature and resistance mechanisms. Data-driven methodologies, particularly those employing Artificial Intelligence (AI), hold substantial promise by advancing a comprehensive understanding of the intricate molecular and cellular mechanisms underlying cancer and supporting the development of adaptive, patient-specific therapeutic strategies. Initiated through the Mertelsmann Foundation, the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg im Breisgau, Germany, aims to drive progress in AI-driven oncology. CRIION fosters global collaboration through initiatives like the Intelligent Oncology Symposium and supports multidisciplinary projects designed to integrate AI innovations into clinical workflows.</p>","PeriodicalId":74384,"journal":{"name":"Oxford open immunology","volume":"6 1","pages":"iqaf004"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103913/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oxford open immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/oxfimm/iqaf004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The molecular complexity of cancer presents significant challenges to traditional therapeutic approaches, necessitating the development of innovative treatment strategies capable of addressing the disease's dynamic nature and resistance mechanisms. Data-driven methodologies, particularly those employing Artificial Intelligence (AI), hold substantial promise by advancing a comprehensive understanding of the intricate molecular and cellular mechanisms underlying cancer and supporting the development of adaptive, patient-specific therapeutic strategies. Initiated through the Mertelsmann Foundation, the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg im Breisgau, Germany, aims to drive progress in AI-driven oncology. CRIION fosters global collaboration through initiatives like the Intelligent Oncology Symposium and supports multidisciplinary projects designed to integrate AI innovations into clinical workflows.

人工智能在优化癌症治疗中的应用:为跨学科发展奠定基础。
癌症的分子复杂性对传统治疗方法提出了重大挑战,需要开发能够解决疾病动态性质和耐药机制的创新治疗策略。数据驱动的方法,特别是那些采用人工智能(AI)的方法,通过推进对癌症背后复杂的分子和细胞机制的全面理解,并支持适应性的、针对患者的治疗策略的发展,具有巨大的前景。由Mertelsmann基金会发起,位于德国弗莱堡的智能肿瘤合作研究所(CRIION)旨在推动人工智能驱动肿瘤学的进展。CRIION通过智能肿瘤学研讨会等倡议促进全球合作,并支持旨在将人工智能创新融入临床工作流程的多学科项目。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信